Search filters

List of works by Aurélien Amiot

2017 WSES guidelines for the management of iatrogenic colonoscopy perforation

scientific article published on 24 January 2018

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease

scientific article published on 22 December 2019

Anti-TNF therapy for genital fistulas in female patients with Crohn's disease: a nationwide study from the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)

scientific article published on 07 September 2018

Dose de-escalation to adalimumab 40 mg every three weeks in patients with inflammatory bowel disease-A multicenter, retrospective, observational study

scientific article published on 08 November 2018

Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study

scientific article published on 14 April 2020

Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis

scientific article published on 13 June 2019

Impact of abdominal or pelvic radiotherapy on disease activity in inflammatory bowel disease: a multicentre cohort study from the GETAID

scientific article published on 26 November 2020

Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort

scientific article

Laparoscopic vs. open surgery for the treatment of iatrogenic colonoscopic perforations: a systematic review and meta-analysis

scientific article published on 06 February 2017

Letter: immunogenicity of infliximab-ready for routine prediction?

scientific article published on 01 April 2020

Letter: long-term outcomes of patients with acute severe ulcerative colitis after intravenous steroid therapy-authors' reply

scientific article published on 01 October 2020

Letter: new insights on tofacitinib dose de-escalation

scientific article published on 01 March 2020

Letter: severe COVID-19 infection and biologic therapies-a cohort study of 7 808 patients in France

scientific article published on 01 October 2020

Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience.

scientific article published on 8 January 2018

Long-term outcome of patients with acute severe ulcerative colitis responding to intravenous steroids

scientific article published on 28 April 2020

One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study.

scientific article

Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)

scientific article published on 02 August 2018

Robotic Versus Laparoscopic Partial Mesorectal Excision for Cancer of the High Rectum: A Single-Center Study with Propensity Score Matching Analysis

scientific article published on 01 July 2020

Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study

scientific article published on 07 December 2020

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents.

scientific article

Switching to biosimilars: current perspectives in immune-mediated inflammatory diseases

scientific article published on 06 May 2019

Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study

scientific article published on 05 June 2019

Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study

scientific article published on 01 September 2019